Demis Hassabis, DeepMind CEO (Qianlong/Imaginechina via AP Images)

Google's Deep­Mind opens its pro­tein data­base to sci­ence — po­ten­tial­ly crack­ing drug R&D wide open

Near­ly a year ago, Google’s AI out­fit Deep­Mind an­nounced they had cracked one of the old­est prob­lems in bi­ol­o­gy: pre­dict­ing a pro­tein’s struc­ture from its se­quence alone. Now they’ve turned that soft­ware on near­ly every hu­man pro­tein and hun­dreds of thou­sands of ad­di­tion­al pro­teins from or­gan­isms im­por­tant to med­ical re­search, such as fruit flies, mice and malar­ia par­a­site.

The new data­base of rough­ly 350,000 pro­tein se­quences and struc­tures rep­re­sents a po­ten­tial­ly mon­u­men­tal achieve­ment for the life sci­ences, one that could has­ten new bi­o­log­i­cal in­sights and the de­vel­op­ment of new drugs. Deep­Mind said it will be free and ac­ces­si­ble to all re­searchers and com­pa­nies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.